Profusa Raises 2026 Revenue Guidance to $1.5M-$3M

Reuters
Yesterday
Profusa Raises 2026 Revenue Guidance to $1.5M-$3M

Profusa Inc. raised its 2026 revenue guidance to $1.5 million–$3.0 million, up from its prior outlook of $0.5 million–$2.0 million. The company attributed the higher expectations to purchase orders for its Lumee tissue oxygen monitoring system in Europe and progress in its Healthcare Research business, signaling stronger anticipated performance in 2026 than previously projected.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Profusa Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9657557-en) on February 19, 2026, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10